Tofacitinib Versus Methotrexate as the First Line DMARD in the Treatment of Rheumatoid Arthritis

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2020
It is a randomized controlled study
Epistemonikos ID: 0ba643f71745f3f8b2b400bfe1f7e10c26ff858f
First added on: Mar 23, 2022